Core Insights - The company, Shijiazhuang Pharmaceutical Group, announced a share buyback on October 14, purchasing 2.1 million shares at a price range of HKD 2.870 to HKD 2.940, totaling HKD 6.09 million [2] - The stock closed at HKD 2.850 on the same day, reflecting a decline of 2.40%, with a total trading volume of HKD 49.30 million [2] - Year-to-date, the company has conducted 15 buybacks, acquiring a total of 43 million shares for a cumulative amount of HKD 127 million [2] Buyback Details - The latest buyback on October 14 involved 210,000 shares, with a maximum price of HKD 2.940 and a minimum price of HKD 2.870, amounting to HKD 6.09 million [2] - Previous buybacks include: - October 10: 150,000 shares at a maximum price of HKD 2.970, totaling HKD 4.43 million [2] - October 8: 200,000 shares at a maximum price of HKD 2.880, totaling HKD 5.73 million [2] - October 6: 300,000 shares at a maximum price of HKD 2.930, totaling HKD 8.70 million [2] - September 23: 500,000 shares at a maximum price of HKD 2.960, totaling HKD 14.67 million [2] - The company has consistently engaged in buybacks throughout the year, indicating a strategy to support its stock price and return value to shareholders [2]
石四药集团(02005.HK)10月14日回购210.00万股，耗资609.08万港元